BeOne and Revolution Medicines partner for oncology therapies
The partnership will focus on developing combination therapies for patients with RAS-addicted cancers.
Drug Development
Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront
Innovent and Daiichi Sankyo sign deal for Vanflyta in China
Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs
Evotec and Odyssey collaborate on AI-enabled R&D
Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments
Alteogen signs $365m Hybrozyme licensing deal with pharma company
Schrödinger and BMS expand partnership to deploy AI for drug discovery
